Better Home & Finance (NASDAQ:BETR) reported third-quarter revenue below its guidance and outlined plans to cut costs, expand home-equity lending and use artificial intelligence to improve productivity as it pursues adjusted EBITDA break-even.
The mortgage lender reported $45.1
Corbus Pharmaceuticals stock: An explosive 342% YTD surgeCorbus Pharmaceuticals (NASDAQ:CRBP) has started a Phase 3 study of its cancer drug CRB-701 and expects an exploratory readout from a separate frontline combination study in the first quarter of next year, CEO Yuval Cohen s
Brutal 2025 for Sarepta—Analysts Still Call for 179% UpsideSarepta Therapeutics (NASDAQ:SRPT) expects updates from its experimental neuromuscular disease programs to help shape its next phase of growth, while relying on its Duchenne muscular dystrophy business to fund development
Biotech & Healthcare Meet AI: Stocks Soar On Innovation PotentialRadNet (NASDAQ:RDNT) reported record third-quarter revenue and adjusted EBITDA as demand for advanced imaging, acquisitions and growth in its Digital Health business helped drive results. The company also raised its
MarketBeat Week in Review – 06/08 - 06/12GSK (NYSE:GSK) is advancing a portfolio of long-acting medicines and combination treatments for respiratory and inflammatory diseases, with a particular focus on chronic obstructive pulmonary disease, a senior research executive said at Gu
3 Biopharmaceutical Stocks Bucking the Sell-OffDBV Technologies (NASDAQ:DBVT) is preparing for a potential U.S. launch of its peanut allergy patch for children ages 4 to 7 while awaiting a decision on whether regulators will accept its biologics license application, executives sa
A Closer Look at Healthcare Sector Earnings: AZN vs. EW vs. ZBHZimmer Biomet (NYSE:ZBH) raised its 2026 sales growth and adjusted earnings outlook after third-quarter growth in hips, surgical specialties and technology offset continued weakness in its knee business.
The orthoped
5 Stocks Showing Why Pricing Power Matters More Than Government MoneyShoulder Innovations (NYSE:SI) raised its full-year revenue outlook after reporting 38% growth in the third quarter, as new surgeon additions and higher use of its implants by existing customers helped offset se
MarketBeat Week in Review – 06/22 - 06/26Sweetgreen (NYSE:SG) reported higher third-quarter revenue despite a decline in comparable sales, as executives said customer traffic recovered through the quarter and continued to improve in October.
Revenue rose approximately 2% to $176
High Yield Revival: 3 Cash-Rich Dividend Payers on SalePerrigo (NYSE:PRGO) reported lower third-quarter sales and earnings as cautious retailer inventory decisions and weakness in Europe weighed on results, even as the self-care company gained market share and narrowed its core s
Industrial Tech Crossovers: When Manufacturing Meets InnovationITT (NYSE:ITT) raised its full-year earnings and cash flow outlook after third-quarter revenue rose 44%, helped by its acquisition of SPX FLOW and organic growth across all three business segments.
The company report
Small Caps Are Crushing the S&P 500—3 Stocks Still Worth BuyingWilldan Group (NASDAQ:WLDN) raised its 2026 financial targets after reporting double-digit revenue growth in the third quarter and closing its acquisition of energy management provider Mantis Innovation. The company a
The Top 3 Medical Devices Stocks to Buy NowBio-Rad Laboratories (NYSE:BIO) reported modest third-quarter revenue growth, its first currency-neutral increase of 2026, as gains in clinical diagnostics and digital PCR instruments helped offset weakness in parts of its life sciences
3 Stocks That Wall Street Insiders Can’t Stop BuyingOPKO Health (NASDAQ:OPK) reported 16% growth in third-quarter revenue from continuing operations and outlined plans to focus on drug development and pharmaceutical products following its proposed sale of BioReference assets to L
Seize the Growth: Twilio’s AI Innovations Are Driving Huge Upside8X8 (NASDAQ:EGHT) raised its fiscal 2027 revenue, earnings and operating cash flow outlook after reporting a sixth consecutive quarter of year-over-year revenue growth, driven in part by demand for usage-based commu
LivaNova (NASDAQ:LIVN) reported third-quarter 2026 revenue growth of 10% from the prior-year period, driven by double-digit gains in its Cardiopulmonary and epilepsy businesses. The medical technology company raised its full-year revenue and adjusted earnings outlook, citing comm
Wall Street Is Betting These 3 Beaten-Down Stocks Have More Room to RunEstee Lauder Companies (NYSE:EL) used its Capital Markets Experience in Shanghai to outline a fiscal 2030 growth and margin plan, citing improving sales momentum, share gains in China, and expanded use of arti
Moderna Just Doubled Overnight, and 2 More Healthcare Stocks Could Follow ItBioCryst Pharmaceuticals (NASDAQ:BCRX) reported third-quarter results marked by growth in ORLADEYO revenue, higher profitability and progress across its hereditary angioedema, or HAE, portfolio, while mai
Hospital Stocks - Best Hospital Stocks to BuyFresenius Medical Care AG & Co. KGaA (NYSE:FMS) reported broadly stable third-quarter revenue and a decline in operating income as reimbursement pressures and inflation weighed on results, while the company continued to advance its U.S
Fortune Brands Innovations (NYSE:FBIN) reported third-quarter results that were pressured by softer new-construction demand, service challenges and margin compression, while outlining a multiyear “Back to Business” plan intended to improve execution, simplify its portfolio and ex